Forbes August 17, 2023
Alison Durkee

Topline

A federal appeals court ruled Wednesday to reinstate restrictions on the abortion drug mifepristone, such as no longer making it available via telehealth, but an April ruling from the Supreme Court means the medication’s availability is still the same as it was before for the foreseeable future, until the high court rules in the case.

Key Facts

What To Watch For

The Supreme Court’s ruling leaves the existing protocols for mifepristone in place until the high court rules in the case, if it decides to take it up, and says the lower court’s ruling will go immediately into effect if justices decide not to hear the case. The Justice Department said Wednesday it “will be seeking Supreme Court review”...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: FDA, Govt Agencies, Patient / Consumer, Provider
208 million Americans are classified as obese or overweight, according to new study on 132 data sources
The Evidence for Gratitude and Health, 2024 Giving Thanks
How 3 Health Systems Are Scaling Hybrid & Home-Based Models
277 million patients' data drives Epic's research findings
Growing gulf in US life expectancy deepened by COVID-19 pandemic

Share This Article